Lele Wang

机构：BGI Group (China), TCL (China), BGI Research · ORCID：0009-0004-7351-9003

发表论文 69 篇 · 总被引 1467 次 · h-index 21

代表论文

• Astragaloside IV mitigates cerebral ischaemia-reperfusion injury via inhibition of P62/Keap1/Nrf2 pathway-mediated ferroptosis (2023 · European Journal of Pharmacology · 被引 107)
• Protective effect of the total flavonoids from Clinopodium chinense against LPS-induced mice endometritis by inhibiting NLRP3 inflammasome-mediated pyroptosis (2023 · Journal of Ethnopharmacology · 被引 28)
• A single-molecule nanopore sequencing platform (2024 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 24)
• Exploring myometrial microenvironment changes at the single-cell level from nonpregnant to term pregnant states (2023 · Physiological Genomics · 被引 20)
• ABBV-744 alleviates LPS-induced neuroinflammation via regulation of BATF2-IRF4-STAT1/3/5 axis (2024 · Acta Pharmacologica Sinica · 被引 15)
• Hypermethylation of CDKN2A CpG island drives resistance to PRC2 inhibitors in SWI/SNF loss-of-function tumors (2024 · Cell Death and Disease · 被引 12)